Rapid achievement of low disease activity during the use of a type I interferon inhibitor in a patient with torpid systemic lupus erythematosus (case report)

Rapid achievement of low disease activity during the use of a type I interferon inhibitor in a patient with torpid systemic lupus erythematosus (case report)

This article describes the experience of using the type I interferon inhibitor anifrolumab (AFM) in a patient with a torpid course of systemic lupus erythematosus. The reason for prescribing AFM was the need for a quick achievement of low disease activity due to a planned hip replacement. Dynamic ob...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Baranov, E. A. Aseeva, S. K. Soloviev, N. Yu. Nikishina, E. A. Malygina, T. O. Abissova, Z. Yu. Pimenova, T. M. Reshetnyak, S. A. Makarov, N. A. Lapkina, A. M. Lila
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2024-06-01
Series:Современная ревматология
Subjects:
systemic lupus erythematosus
interferon receptors
interferon α
anifrolumab
Online Access:https://mrj.ima-press.net/mrj/article/view/1591
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items